SCHEMBL3658341

SCHEMBL3658341

NC1(C(=O)O)COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2805443 0.79
SCHEMBL16868374 0.79
SCHEMBL185263 0.79
Hydrochloric Acid SCHEMBL3032015 0.78 NSD2 (0.39)
SCHEMBL29821839 0.77
SCHEMBL29955088 0.76 NSD2 (0.38)
SCHEMBL29954390 0.76 NSD2 (0.38)
SCHEMBL7123682 0.76 NSD2 (0.38)
SCHEMBL25788612 0.74
Acetic Acid SCHEMBL20659117 0.74 FFAR3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025245483-A1 METHODS AND COMPOSITIONS FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) 2025-11-27 WO claimed
US-20250361273-A1 METHODS AND COMPOSITIONS FLAGSHIP PIONEERING INNOVATIONS VII, LLC 2025-11-27 US claimed
CN-119285581-A Synthesis method of 3-amino oxetane-3-formic acid 长沙瀚辰生物科技有限公司 2025-01-10 CN claimed
CN-118853310-A Environment-friendly nano suspension cleaning agent and preparation method thereof 洛阳泽铭清洗设备有限公司 2024-10-29 CN claimed
EP-4429872-A1 VAT POLYMERIZATION PROCESS Polyfos 3D Ltd (IL) 2024-09-18 EP claimed
CN-118388092-B Cooperative treatment process for hospital sewage 河北旺效环保工程有限公司 2024-09-17 CN claimed
CN-118388092-A Cooperative treatment process for hospital sewage 河北旺效环保工程有限公司 2024-07-26 CN claimed
WO-2023084517-A1 VAT POLYMERIZATION PROCESS POLYFOS 3D LTD (IL) 2023-05-19 WO claimed
EP-2668155-B1 NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-11-26 EP claimed
US-20130018055-A1 NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2013-01-17 US claimed
US-12590062-B2 PD-1/PD-L1 inhibitors GILEAD SCIENCES, INC. (US) 2026-03-31 US disclosed
WO-2025245483-A1 METHODS AND COMPOSITIONS FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) 2025-11-27 WO disclosed
US-20250361273-A1 METHODS AND COMPOSITIONS FLAGSHIP PIONEERING INNOVATIONS VII, LLC 2025-11-27 US disclosed
US-12410212-B2 Cyclic compound having selective KRAS inhibitory effect on HRAS and NRAS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-09-09 US disclosed
EP-4603105-A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLIC COMPOUND HAVING SELECTIVE KRAS INHIBITORY EFFECT AGAINST HRAS AND NRAS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-08-20 EP disclosed
US-20120165338-A1 NEW BIARYL AMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. 2012-06-28 US disclosed
WO-2012075456-A1 BROMODOMAIN INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS (US) 2012-06-07 WO disclosed
WO-2012075456-A1 BROMODOMAIN INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS (US) 2012-06-07 WO disclosed
EP-2225238-A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZOÝ1,2- ¨IMIDAZOLE-3- CARBOXYLIC ACID AMIDES Boehringer Ingelheim International GmbH (DE) 2010-09-08 EP disclosed
WO-2009070485-A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-06-04 WO disclosed